Genetically modified T cells could be manufactured inside the body and provide clinical improvements in adults with severe neurological autoimmune diseases, according to preliminary findings.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Wuhan – An in vivo variant of CAR-T cell therapy, in which the T cells are equipped with a chimeric antigen receptor (CAR) with the help of lentiviruses, has eased disease activity in individuals with multiple sclerosis and some other neurological autoimmune diseases in an ongoing phase 1 study. Chinese...
Genetically modified T cells could be manufactured inside the body and provide clinical improvements in adults with severe neurological autoimmune diseases, according to preliminary findings.